{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:30:36Z","timestamp":1773289836117,"version":"3.50.1"},"reference-count":19,"publisher":"Japanese Society of Toxicology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2131\/jts.42.499","type":"journal-article","created":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T22:34:41Z","timestamp":1499985281000},"page":"499-507","source":"Crossref","is-referenced-by-count":20,"title":["Utility of human hepatocyte spheroids without feeder cells for evaluation of hepatotoxicity"],"prefix":"10.2131","volume":"42","author":[{"given":"Takuo","family":"Ogihara","sequence":"first","affiliation":[{"name":"Laboratory of Biopharmaceutics, Department of Pharmacology, Faculty of Pharmacy, Takasaki University of Health and Welfare"},{"name":"Laboratory of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences,Takasaki University of Health and Welfare"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Arakawa","sequence":"additional","affiliation":[{"name":"Laboratory of Biopharmaceutics, Department of Pharmacology, Faculty of Pharmacy, Takasaki University of Health and Welfare"},{"name":"Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Jomura","sequence":"additional","affiliation":[{"name":"Biotech Application Group Research and Development, Toyo Gosei Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Idota","sequence":"additional","affiliation":[{"name":"Laboratory of Biopharmaceutics, Department of Pharmacology, Faculty of Pharmacy, Takasaki University of Health and Welfare"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Koyama","sequence":"additional","affiliation":[{"name":"Laboratory of Biopharmaceutics, Department of Pharmacology, Faculty of Pharmacy, Takasaki University of Health and Welfare"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Yano","sequence":"additional","affiliation":[{"name":"Laboratory of Biopharmaceutics, Department of Pharmacology, Faculty of Pharmacy, Takasaki University of Health and Welfare"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Kojima","sequence":"additional","affiliation":[{"name":"Division of Risk Assessment, Biological Safety Research Center, National Institute of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Arakawa, H., Kamioka, H., Jomura, T., Koyama, S., Idota, Y., Yano, K., Kojima, H. and Ogihara, T. (2017): Preliminary evaluation of three-dimensional primary human hepatocyte culture system for assay of drug-metabolizing enzyme-inducing potential. Biol. Pharm. Bull., Accepted.","DOI":"10.1248\/bpb.b16-00885"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Bort, R., Ponsoda, X., Jover, R., G\u00f3mez-Lech\u00f3n, M.J. and Castell, J.V. (1999): Diclofenac toxicity to hepatocytes: a role for drug metabolism in cell toxicity. J. Pharmacol. Exp. Ther., <b>288<\/b>, 65-72.","DOI":"10.1016\/S0022-3565(24)37925-X"},{"key":"3","unstructured":"Crompton, M., Ellinger, H. and Costi, A. (1988): Inhibition by cyclosporin A of a Ca<sup>2+<\/sup>-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem. J., <b>255<\/b>, 357-360."},{"key":"4","doi-asserted-by":"crossref","unstructured":"Domansky, K., Inman, W., Serdy, J., Dash, A., Lim, M.H. and Griffith, L.G. (2010): Perfused multiwell plate for 3D liver tissue engineering. Lab. Chip., <b>10<\/b>, 51-58.","DOI":"10.1039\/B913221J"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Gerets, H.H., Tilmant, K., Gerin, B., Chanteux, H., Depelchin, B.O., Dhalluin, S. and Atienzar, F.A. (2012): Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol. Toxicol., <b>28<\/b>, 69-87.","DOI":"10.1007\/s10565-011-9208-4"},{"key":"6","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Lech\u00f3n, M.J., Ponsoda, X., Bort, R. and Castell, J.V. (2001): The use of cultured hepatocytes to investigate the metabolism of drugs and mechanisms of drug hepatotoxicity. Altern. Lab. Anim., <b>29<\/b>, 225-231.","DOI":"10.1177\/026119290102900307"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Guillouzo, A. and Guguen-Guillouzo, C. (2008): Evolving concepts in liver tissue modeling and implications for <i>in vitro<\/i> toxicology. Expert. Opin. Drug Metab. Toxicol., <b>4<\/b>, 1279-1294.","DOI":"10.1517\/17425255.4.10.1279"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Hewitt, N.J., Lech\u00f3n, M.J., Houston, J.B., Hallifax, D., Brown, H.S., Maurel, P., Kenna, J.G., Gustavsson, L., Lohmann, C., Skonberg, C., Guillouzo, A., Tuschl, G., Li, A.P., LeCluyse, E., Groothuis, G.M. and Hengstler, J.G. (2007): Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metab. Rev., <b>39<\/b>, 159-234.","DOI":"10.1080\/03602530601093489"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Lasser, K.E., Allen, P.D., Woolhandler, S.J., Himmelstein, D.U., Wolfe, S.M. and Bor, D.H. (2002): Timing of new black box warnings and withdrawals for prescription medications. J. Am. Med. Assoc., <b>287<\/b>, 2215-2220.","DOI":"10.1001\/jama.287.17.2215"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Lauschke, V.M., Hendriks, D.F., Bell, C.C., Andersson, T.B. and Ingelman-Sundberg, M. (2016): Novel 3D Culture Systems for Studies of Human Liver Function and Assessments of the Hepatotoxicity of Drugs and Drug Candidates. Chem. Res. Toxicol., <b>29<\/b>, 1936-1955.","DOI":"10.1021\/acs.chemrestox.6b00150"},{"key":"11","doi-asserted-by":"crossref","unstructured":"McKenzie, R., Fried, M.W., Sallie, R., Conjeevaram, H., Di Bisceglie, A.M., Park, Y., Savarese, B., Kleiner, D., Tsokos, M., Luciano, C. <i>et al<\/i>. (1995): Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N. Engl. J. Med., <b>333<\/b>, 1099-1105.","DOI":"10.1056\/NEJM199510263331702"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Meng, Q. (2010): Three-dimensional culture of hepatocytes for prediction of drug-induced hepatotoxicity. Expert. Opin. Drug Metab. Toxicol., <b>6<\/b>, 733-746.","DOI":"10.1517\/17425251003674356"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Ogihara, T., Iwai, H., Inoue, Y., Katagi, J., Matsumoto, N., Motoi-Ohtsuji, M., Kakiki, M., Kaneda, S., Nagao, T., Kusumoto, K., Ozeki, E., Jomura, T., Tanaka, S., Ueda, T., Ohta, K., Ohkura, T., Arakawa, H. and Nagai, D. (2015): Utility of human hepatocyte spheroids for evaluation of hepatotoxicity. Fundam. Toxicol. Sci., <b>2<\/b>, 41-48.","DOI":"10.2131\/fts.2.41"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Ohkura, T., Ohta, K., Nagao, T., Kusumoto, K., Koeda, A., Ueda, T., Jomura, T., Ikeya, T., Ozeki, E., Wada, K., Naitoh, K., Inoue, Y., Takahashi, N., Iwai, H., Arakawa, H. and Ogihara, T. (2014): Evaluation of human hepatocytes cultured by three-dimensional spheroid systems for drug metabolism. Drug Metab. Pharmacokinet., <b>29<\/b>, 373-378.","DOI":"10.2133\/dmpk.DMPK-13-RG-105"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., Dorato, M., Van Deun, K., Smith, P., Berger, B. and Heller, A. (2000): Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul. Toxicol. Pharmacol., <b>32<\/b>, 56-67.","DOI":"10.1006\/rtph.2000.1399"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Regenthal, R., Krueger, M., Koeppel, C. and Preiss, R. (1999): Drug levels: therapeutic and toxic serum\/plasma concentrations of common drugs. J. Clin. Monit. Comput., <b>15<\/b>, 529-544.","DOI":"10.1023\/A:1009935116877"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Tujios, S. and Fontana, R.J. (2011): Mechanisms of drug-induced liver injury: from bedside to bench. Nat. Rev. Gastroenterol. Hepatol., <b>8<\/b>, 202-211.","DOI":"10.1038\/nrgastro.2011.22"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Wang, K., Shindoh, H., Inoue, T. and Horii, I. (2002): Advantages of <i>in vitro<\/i> cytotoxicity testing by using primary rat hepatocytes in comparison with established cell lines. J. Toxicol. Sci.,<b> 27<\/b>, 229-237.","DOI":"10.2131\/jts.27.229"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Xu, J.J., Henstock, P.V., Dunn, M.C., Smith, A.R., Chabot, J.R. and de Graaf, D. (2008): Cellular imaging predictions of clinical drug-induced liver injury. Toxicol. Sci., <b>105<\/b>, 97-105.","DOI":"10.1093\/toxsci\/kfn109"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/42\/4\/42_499\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T19:37:55Z","timestamp":1750621075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/42\/4\/42_499\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.42.499","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}